June 3 marks the Rare Connections summit in New York, hosted by Kedrion Biopharma and InstaLILY. Industry leaders will discuss deploying responsible AI within highly regulated medical environments. The event focuses on practical implementation over theoretical hype. Practitioners can expect a blueprint for navigating compliance while scaling clinical AI tools.